X
KEY PRODUCTS
https://www.midas-pharma.com/en/latest-activities/gx-inbeneo-platform-simulator/
https://www.midas-pharma.com/en/latest-activities/new-development-partnership-with-apontis-pharma/
https://www.midas-pharma.com/en/latest-activities/ranibizumab-launch/
https://www.midas-pharma.com/en/latest-activities/midas-pharma-uses-ipma-standards-in-project-management/
https://www.pharmacompass.com/pdf/news/midass-ranivisio-ranibizumab-receives-approval-in-europe-17510.pdf
https://www.midas-pharma.com/en/latest-activities/apontis-pharma-and-midas-pharma-agree-on-further-development-partnership/
https://www.midas-pharma.com/en/latest-activities/midas-pharma-engages-in-working-group-of-the-oav-and-gha/
https://www.midas-pharma.com/en/latest-activities/midas-pharma-receives-cep-for-propofol/
https://www.midas-pharma.com/en/latest-activities/midas-api-crotamiton-has-been-successfully-approved-in-china/
https://www.midas-pharma.com/en/latest-activities/midas-pharma-obtains-cep-for-clofazimine/
Market Place
Share 
